Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer
incidence and mortality rates differ substantially across the world, reflecting varying patterns …

Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

Abstract African American/Black individuals have a disproportionate cancer burden,
including the highest mortality and the lowest survival of any racial/ethnic group for most …

Lung cancer is the leading cause of mortality and person-years of life lost from cancer
among US men and women. Early detection has been shown to be associated with reduced …

Each year, the American Cancer Society estimates the numbers of new cancer cases and
deaths in the United States and compiles the most recent data on population-based cancer …

Simple Summary Diagnosing cancer at an early stage increases the chance of performing
effective treatment in many tumour groups. Key approaches include screening patients who …

Despite a consistent decline in incidence and mortality for more than a decade, lung cancer
continues to rank as the leading cause of cancer mortality. 1, 2 In incidence it is second only …

PURPOSE Low-dose computed tomography (LDCT) for lung cancer screening is effective,
although most eligible people are not being screened. Tools that provide personalized …

Importance Health care was disrupted in the US during the first quarter of 2020 with the
emergence of the COVID-19 pandemic. Early reports in selected samples suggested that …

The NCCN Guidelines for Lung Cancer Screening recommend criteria for selecting
individuals for screening and provide recommendations for evaluation and follow-up of lung …